From: The evidence for improving housing to reduce malaria: a systematic review and meta-analysis
Comparison | Outcome | Study design | Total studies | Effect estimate |
---|---|---|---|---|
(95Â % CI) | ||||
1 Modern versus traditional housing | 1.1 Malaria infection | 1.1.1 Case–control, cross-sectional and cohort studies (crude OR) | 9 | 0.46 [0.33, 0.62] |
1.1.2 Case–control, cross-sectional and cohort studies (adjusted OR) | 5 | 0.53 [0.42, 0.67] | ||
1.2 Clinical malaria | 1.2.1 Case–control and cross-sectional studies (crude OR) | 1 | 0.32 [0.19, 0.54] | |
1.2.2 Case–control and cross-sectional studies (adjusted OR) | 1 | 0.35 [0.20, 0.62] | ||
1.2.3 Cohort studies (crude RR) | 3 | 0.22 [0.14, 0.35] | ||
1.2.4 Cohort studies (adjusted RR) | 3 | 0.55 [0.36, 0.84] | ||
2 Screening1 | 2.1 Anaemia in children aged 0–11 years | 2.1.1 Randomized controlled trials (adjusted OR) | 1 | 0.52 [0.34, 0.80] |
2.1.2 Case–control, cross-sectional and cohort studies (crude OR) | 2 | 0.65 [0.33, 1.30] | ||
2.1.3 Case–control, cross-sectional and cohort studies (adjusted OR) | 1 | 0.56 [0.24, 1.27] | ||
2.2 Malaria infection | 2.2.1 Randomized controlled trials (adjusted OR) | 1 | 0.95 [0.63, 1.43] | |
2.2.2 Case–control, cross-sectional and cohort studies (crude OR) | 5 | 0.35 [0.13, 0.98] | ||
2.2.3 Case–control, cross-sectional and cohort studies (adjusted OR) | 2 | 0.93 [0.82, 1.05] | ||
2.3 Clinical malaria | 2.3.1 Case–control and cross-sectional studies (crude OR) | 1 | 1.16 [0.82, 1.64] | |
2.3.2 Cohort studies (crude RR) | 5 | 0.71 [0.49, 1.04] | ||
2.3.3 Cohort studies (adjusted RR) | 3 | 0.56 [0.46, 0.67] | ||
3 Main wall material2 | 3.1 Anaemia in children aged 0–11 years | 3.1.1 Case–control, cross-sectional and cohort studies (crude OR) | 1 | 0.58 [0.33, 1.02] |
3.1.2 Case–control, cross-sectional and cohort studies (adjusted OR) | 1 | 0.57 [0.29, 1.12] | ||
3.2 Malaria infection | 3.2.1 Case–control, cross-sectional and cohort studies (crude OR) | 12 | 0.57 [0.42, 0.78] | |
3.2.2 Case–control, cross-sectional and cohort studies (adjusted OR) | 7 | 0.73 [0.62, 0.85] | ||
3.3 Clinical malaria | 3.3.1 Case–control and cross-sectional studies (crude OR) | 7 | 0.63 [0.43, 0.93] | |
3.3.2 Case–control and cross-sectional studies (adjusted OR) | 1 | 0.16 [0.06, 0.44] | ||
3.3.3 Cohort studies (crude RR) | 1 | 2.07 [1.18, 3.63] | ||
3.3.4 Cohort studies (adjusted RR) | 2 | 1.05 [0.48, 2.30] | ||
4 Main roof material2 | 4.1 Anaemia in children aged 0–11 years | 4.1.1 Case–control, cross-sectional and cohort studies (crude OR) | 1 | 0.71 [0.45, 1.12] |
4.2 Malaria infection | 4.2.1 Case–control, cross-sectional and cohort studies (crude OR) | 9 | 0.64 [0.48, 0.86] | |
4.2.2 Case–control, cross-sectional and cohort studies (adjusted OR) | 6 | 0.83 [0.64, 1.08] | ||
4.3 Clinical malaria | 4.3.1 Case–control and cross-sectional studies (crude OR) | 4 | 0.86 [0.48, 1.53] | |
4.3.2 Case–control and cross-sectional studies (adjusted OR) | 1 | 0.30 [0.13, 0.66] | ||
4.3.3 Cohort studies (crude RR) | 2 | 0.59 [0.52, 0.67] | ||
4.3.4 Cohort studies (adjusted RR) | 3 | 0.79 [0.70, 0.88] | ||
5 Main floor material2 | 5.1 Anaemia in children aged 0–11 years | 5.1.1 Case–control, cross-sectional and cohort studies (crude OR) | 1 | 0.78 [0.45, 1.34] |
5.2 Malaria infection | 5.2.1 Case–control, cross-sectional and cohort studies (crude OR) | 1 | 1.20 [0.69, 2.09] | |
5.2.2 Case–control, cross-sectional and cohort studies (adjusted OR) | 2 | 0.74 [0.57, 0.96] | ||
5.3 Clinical malaria | 5.3.1 Case–control and cross-sectional studies (crude OR) | 1 | 0.19 [0.06, 0.57] | |
5.3.2 Cohort studies (adjusted RR) | 1 | 0.81 [0.62, 1.06] | ||
6 Eaves3 | 6.1 Malaria infection | 6.1.1 Case–control, cross-sectional and cohort studies (crude OR) | 4 | 0.70 [0.58, 0.84] |
6.1.2 Case–control, cross-sectional and cohort studies (adjusted OR) | 3 | 0.78 [0.70, 0.87] | ||
6.2 Clinical malaria | 6.2.1 Case–control and cross-sectional studies (crude OR) | 5 | 0.76 [0.55, 1.07] | |
6.2.2 Case–control and cross-sectional studies (adjusted OR) | 1 | 0.53 [0.36, 0.80] | ||
6.2.3 Cohort studies (crude RR) | 1 | 0.75 [0.50, 1.12] | ||
6.2.4 Cohort studies (adjusted RR) | 2 | 0.71 [0.46, 1.11] | ||
7 Ceiling4 | 7.1 Clinical malaria | 7.1.1 Case–control and cross-sectional studies (crude OR) | 3 | 0.68 [0.56, 0.83] |
7.1.2 Case–control and cross-sectional studies (adjusted OR) | 1 | 0.65 [0.46, 0.93] | ||
8 Elevation5 | 8.1 Malaria infection | 8.1.1 Case–control and cross-sectional studies (crude OR) | 1 | 1.00 [1.00, 1.00] |